The test focused on certain features of blood cells and electrical activity in people with ME/CFS
Venter C, Meyer RW, Nwaru BI, Roduit C, Untersmayr E, Adel-Patient K, Agache I, Agostoni C, Akdis CA, Bischoff SC, du Toit G, Feeney M, Frei R, Garn H, Greenhawt M, Hoffmann-Sommergruber K, Lunjani N, Maslin K, Mills C, Muraro A, Pali-Schll I, Poulson LK, Reese I, Renz H, Roberts GC, Smith P, Smolinska S, Sokolowska M, Stanton C, Vlieg-Boerstra B, OMahony L
Certain populations require cautious evaluation: patients with a history of medullary thyroid carcinoma, personal or family history of multiple endocrine neoplasia type 2, severe kidney disease, or acute pancreatitis should not use GLP-1 agents
[9] Seek urgent medical attention (call 111, contact your GP urgently, or attend A&E) if you develop: Severe, persistent abdominal pain , particularly if it radiates to the back, as this may indicate pancreatitisa rare but serious adverse effect of GLP-1 agonists
When comparing which is better Semaglutide or Tesamorelin , the answer depends on individual goals within medical weight loss programs and provider recommendations
